January 24, 2021
General News

Brazil researchers report disappointing 50.4% efficacy for CoronaVac

This post was originally published on this site

A coronavirus vaccine developed by China’s Sinovac showed “general efficacy” of 50.4% in a late-stage trial in Brazil, researchers said on Tuesday, barely enough for regulatory approval and far short of earlier indications.